{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T09:01:22Z","timestamp":1776848482925,"version":"3.51.2"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.revmed.2018.04.018","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T19:15:35Z","timestamp":1525806935000},"page":"151-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Lymph\u0153d\u00e8mes associ\u00e9s \u00e0 la prise de sirolimus\u00a0: \u00e0 propos de 15\u00a0patients"],"prefix":"10.1016","volume":"40","author":[{"given":"C.","family":"Fourgeaud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Benoughidane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Vignes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2018.04.018_bib0165","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5002112","article-title":"Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis","volume":"71","author":"Huber","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.revmed.2018.04.018_bib0170","first-page":"86","article-title":"Sirolimus in the treatment of vascular anomalies","volume":"27","author":"Triana","year":"2017","journal-title":"Eur J Pediatr Surg"},{"key":"10.1016\/j.revmed.2018.04.018_bib0175","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2174\/156800908786733513","article-title":"mTOR pathway and mTOR inhibitors as agents for cancer therapy","volume":"8","author":"Baldo","year":"2008","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.revmed.2018.04.018_bib0180","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/bjd.15883","article-title":"The effects of sirolimus on Kasabach-Merritt phenomenon coagulopathy","volume":"178","author":"Boccara","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2018.04.018_bib0185","doi-asserted-by":"crossref","first-page":"403280","DOI":"10.1155\/2013\/403280","article-title":"Systemic and nonrenal adverse effects occurring in renal transplant patients treated with mTOR inhibitors","volume":"2013","author":"Zaza","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.revmed.2018.04.018_bib0190","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/01.TP.0000118406.01509.75","article-title":"Lymphedema associated with sirolimus in renal transplant recipients","volume":"77","author":"Aboujaoude","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.revmed.2018.04.018_bib0195","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.transproceed.2004.12.180","article-title":"Severe limb lymphedema in sirolimus-treated patients","volume":"37","author":"Romagnoli","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.revmed.2018.04.018_bib0200","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.transproceed.2007.03.058","article-title":"Lymphedema: an unusual complication of sirolimus therapy","volume":"39","author":"Al-Otaibi","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.revmed.2018.04.018_bib0205","first-page":"357","article-title":"One-sided limb lymphedema in a liver transplant recipient receiving sirolimus","volume":"70","author":"Van Onna","year":"2007","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.revmed.2018.04.018_bib0210","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1399-0012.2007.00766.x","article-title":"Generalized lymphedema in a sirolimus-treated renal transplant patient","volume":"22","author":"De Bartolomeis","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1016\/j.revmed.2018.04.018_bib0215","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/j.1365-2133.2009.09098.x","article-title":"Sirolimus-associated lymphoedema: eight new cases and a proposed mechanism","volume":"160","author":"Desai","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2018.04.018_bib0220","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1157\/13125525","article-title":"mTOR inhibitors and unilateral edema","volume":"61","author":"Moro","year":"2008","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.revmed.2018.04.018_bib0225","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1440-1797.2010.01323.x","article-title":"Unilateral upper limb lymphatic obstruction and severe lymphoedema in a patient on long-term sirolimus","volume":"15","author":"Damasiewicz","year":"2010","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.revmed.2018.04.018_bib0230","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/jamadermatol.2014.158","article-title":"Chronic lymphedema in renal transplant recipients under immunosuppression with sirolimus: presentation of 2\u00a0cases","volume":"150","author":"Baliu","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.revmed.2018.04.018_bib0235","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2340\/00015555-1889","article-title":"Sirolimus-induced Inflammatory Lymphedema of the Breast Resolved After Switching to Cyclosporine","volume":"95","author":"Tauveron","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.revmed.2018.04.018_bib0240","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/lrb.2014.0005","article-title":"Large-volume sirolimus-induced upper limb lymphedema after renal transplantation ipsilateral to the arteriovenous fistula","volume":"12","author":"Vignes","year":"2014","journal-title":"Lymphat Res Biol"},{"key":"10.1016\/j.revmed.2018.04.018_bib0245","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.annder.2015.01.020","article-title":"Sirolimus-induced lymphedema in a kidney-transplant recipient: partial recovery after changeover to tacrolimus","volume":"142","author":"Al Gain","year":"2015","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.revmed.2018.04.018_bib0250","doi-asserted-by":"crossref","first-page":"886","DOI":"10.7196\/SAMJ.2016.v106i9.10636","article-title":"Sirolimus-induced lymphoedema","volume":"106","author":"Motse","year":"2016","journal-title":"S Afr Med J"},{"key":"10.1016\/j.revmed.2018.04.018_bib0255","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.12659\/AJCR.905962","article-title":"Lymphedema, pleural effusion, renal transplant and sirolimus","volume":"18","author":"Rashid-Farokhi","year":"2017","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.revmed.2018.04.018_bib0260","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/026835558600100308","article-title":"Indirect lymphoscintigraphy in patients with limb edemas","volume":"1","author":"Pecking","year":"1986","journal-title":"Phlebology"},{"key":"10.1016\/j.revmed.2018.04.018_bib0265","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/00007890-200209270-00012","article-title":"Incidence, therapy, and consequences of lymphocele after sirolimus-cyclosporine-prednisone immunosuppression in renal transplant recipients","volume":"74","author":"Langer","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.revmed.2018.04.018_bib0270","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0041-1345(02)03093-2","article-title":"Increased frequency of lymphoceles under treatment with sirolimus following renal transplantation: a single center experience","volume":"34","author":"Giessing","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1016\/j.revmed.2018.04.018_bib0275","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.transproceed.2008.02.074","article-title":"Chylous ascites in a renal transplant recipient under sirolimus (rapamycin) treatment","volume":"40","author":"Castro","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.revmed.2018.04.018_bib0280","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/ckj\/sfu001","article-title":"Oedema, solid organ transplantation and mammalian target of rapamycin inhibitor\/proliferation signal inhibitors (mTOR-I\/PSIs)","volume":"7","author":"Gharbi","year":"2014","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.revmed.2018.04.018_bib0285","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/01.TP.0000151630.25127.3A","article-title":"Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy","volume":"79","author":"Mah\u00e9","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.revmed.2018.04.018_bib0290","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.transproceed.2012.08.005","article-title":"How often do we face side effects of sirolimus in pediatric renal transplantation?","volume":"45","author":"Fidan","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.revmed.2018.04.018_bib0295","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1016\/j.transproceed.2009.07.094","article-title":"Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion","volume":"41","author":"Sayin","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.revmed.2018.04.018_bib0300","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1399-3046.2007.00749.x","article-title":"Sirolimus in chronic allograft nephropathy in pediatric recipients","volume":"11","author":"Ib\u00e1\u00f1ez","year":"2007","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.revmed.2018.04.018_bib0305","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/00007890-200107150-00031","article-title":"Sirolimus-associated eyelid edema in kidney transplant recipients","volume":"72","author":"Mohaupt","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.revmed.2018.04.018_bib0310","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.chest.2017.05.012","article-title":"Long-term effect of sirolimus on serum vascular endothelial growth factor D levels in patients with lymphangioleiomyomatosis","volume":"153","author":"Taveira-DaSilva","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2018.04.018_bib0315","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.revmed.2016.07.005","article-title":"Les lymph\u0153d\u00e8mes: du diagnostic au traitement","volume":"38","author":"Vignes","year":"2017","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2018.04.018_bib0160","doi-asserted-by":"crossref","first-page":"296","DOI":"10.6002\/ect.2011.0139","article-title":"Everolimus-induced lymphedema in a renal transplant recipient: a case report","volume":"10","author":"Ersoy","year":"2012","journal-title":"Exp Clin Transplant"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866318305290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866318305290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:40:11Z","timestamp":1759336811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866318305290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0248866318305290"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2018.04.018","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymph\u0153d\u00e8mes associ\u00e9s \u00e0 la prise de sirolimus\u00a0: \u00e0 propos de 15\u00a0patients","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2018.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}